C heng Xianfeng is the chairman of Yifan Pharmaceutical, a prominent Chinese pharmaceutical company engaged in the research, development, and production of macromolecule biological drugs and chemical medicines. The company, headquartered in Hangzhou, supplies ingredients for skin and healthcare products, as well as feed additives. Cheng has led Yifan's strategic expansion, securing approvals for over 300 drugs across various therapeutic areas including gynecology, pediatrics, and dermatology.
Under his guidance, Yifan has established a global R&D network with centers in San Francisco, Shanghai, Beijing, Hangzhou, and Hefei. The company focuses on developing innovative therapies to address unmet medical needs. Cheng's leadership has been crucial in positioning Yifan as a significant player in both the domestic and international pharmaceutical markets.
Advertisement
Cheng Xianfeng is a Chinese businessman and billionaire, the Chairman of Yifan Pharmaceutical (SZSE: 002019), a major supplier of ingredients for skin and healthcare products, as well as feed additives.
His company, Yifan, has approvals for the sale of more than 300 drugs across diverse therapeutic areas including gynecology, pediatrics and dermatology. Yifan was established in 1990 and is headquartered in Hangzhou, China.
Cheng Xianfeng's strategic leadership has driven Yifan Pharmaceutical's growth through diversification into high-value specialty drugs and global R&D. His structural contribution is tied to building a pharmaceutical platform with a strong pipeline and broad regulatory approvals across China.
The company's investment in research centers in both China and the U.S. (San Francisco) highlights a commitment to global standards and R&D excellence. His wealth is derived from his stake in the publicly traded company.
Advertisement
Yifan Pharmaceutical's precursor is established.
Yifan Pharmaceutical is officially founded.
Serves as Chairman of Directors and General Manager.
Cheng Xianfeng's wealth is concentrated in his controlling stake and continued leadership of the publicly traded Yifan Pharmaceutical.
Advertisement
Advertisement
No publicly available quotes.
Advertisement
-0.14% | -$5.99M
+0.14% | +$2.30M
This profile is compiled from verified biographical and financial records:
All information is cross-referenced with public sources for accuracy; some narrative sections are AI-assisted summaries.
If you find any inaccuracies, please report them to admin@redcarpetlife.in
Sponsored Content